European Biotech Acquisition (European Biotech Acquisition) Common Stock : $129.26 Mil (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is European Biotech Acquisition Common Stock?

European Biotech Acquisition's quarterly common stock increased from Jun. 2022 ($127.64 Mil) to Sep. 2022 ($128.22 Mil) and increased from Sep. 2022 ($128.22 Mil) to Dec. 2022 ($129.26 Mil).

European Biotech Acquisition's annual common stock increased from . 20 ($0.00 Mil) to Dec. 2021 ($127.55 Mil) and increased from Dec. 2021 ($127.55 Mil) to Dec. 2022 ($129.26 Mil).

European Biotech Acquisition Common Stock Historical Data

The historical data trend for European Biotech Acquisition's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Biotech Acquisition Common Stock Chart

European Biotech Acquisition Annual Data

Trend

Dec21

Dec22

Common Stock

127.55

129.26

European Biotech Acquisition Quarterly Data
	Jan21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Common Stock	Get a 7-Day Free Trial			127.55	127.55	127.64	128.22	129.26

European Biotech Acquisition Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

European Biotech Acquisition (European Biotech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » European Biotech Acquisition Corp (NAS:EBACU) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

EPFL Innovation Park Building, Lausanne, CHE, 1015

Website

https://www.lspvc.com

European Biotech Acquisition Corp is a blank check company.

Executives

Mohammad Sohail Fazeli	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Martijn Kleijwegt	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Volkert H. Doeksen	director	RIOUWSTRAAT 10, THE HAGVE P7 2585HA
Fernandez De Araoz Eduardo Bravo	officer: Chief Executive Officer	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Koen Sintnicolaas	officer: Chief Financial Officer	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Sponsor Ebac B.v.	10 percent owner	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Van De Stolpe Onno	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM, P7 1071 DV
Marcus Antonius Wegter	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Management Group B.v.	10 percent owner	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV

European Biotech Acquisition (European Biotech Acquisition) Headlines

From GuruFocus

European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing May 6, 2021

By Business Wire Business Wire • 05-04-2021

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

By Business Wire Business Wire • 06-04-2021